SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,321.40 -194.03
( -0.25%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

145.1556811

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

466.54

14715.34

EPS(TTM)

Face Value()

Div & Yield %

1.98

0.54

Back

Control Print consolidated net profit declines 52.94% in the June 2026 quarter

Jul 23,2026

Net profit of Control Print declined 52.94% to Rs 3.92 crore in the quarter ended June 2026 as against Rs 8.33 crore during the previous quarter ended June 2025. Sales rose 3.84% to Rs 115.56 crore in the quarter ended June 2026 as against Rs 111.29 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	115.56	111.29	4
OPM %	13.24	16.70	-
PBDT	14.61	18.27	-20
PBT	9.82	13.86	-29
NP	3.92	8.33	-53

76,321.40 -194.03 ( -0.25%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)